Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -68.1133.8294.6045.00-24.35

What is the latest Core EBITDA Growth ratio of VAISHALI PHARMA ?

The latest Core EBITDA Growth ratio of VAISHALI PHARMA is -68.11 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024-68.11
Mar202333.82
Mar202294.60
Mar202145.00
Mar2020-24.35

How is Core EBITDA Growth of VAISHALI PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 -68.11
Negative
Mar2023 33.82
-64.25
Mar2022 94.6
110.22
Mar2021 45
Positive
Mar2020 -24.35 -

Other Financial Ratios of VAISHALI PHARMA


Compare Core EBITDA Growth ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹148.8 Cr -5.7% -7.2% -27.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,648.0 Cr -4.9% 2.1% 15.5% Stock Analytics
DIVIS LABORATORIES ₹159,310.0 Cr -2.2% 9.3% 50.5% Stock Analytics
CIPLA ₹119,410.0 Cr -4.2% 4.5% 4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,189.0 Cr -4.4% -4.5% 17.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,496.4 Cr -1.4% 4.2% -8.8% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-5.7%

-7.2%

-27.1%

SENSEX

-1.3%

4.1%

7.6%


You may also like the below Video Courses